Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane vs Sevoflurane in EVAR
NCT03917186Phase 4Completed
- Start
- Sep 2017
- Primary completion
- Dec 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of desflurane (2 arms). Primary endpoint: Change in Biochemical parameters at 24 hours. Started Sep 2017; status: completed.
02
Drugs
desflurane
Beyond the preview
Go deeper on NCT03917186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03917186.